8-K: Artificial Intelligence Technology Solutions Secures Up to $30 Million Equity Financing Facility

Artificial Intelligence Technology Solutions Inc. has entered into an Equity Financing Agreement with GHS Investments, LLC for the potential sale of up to $30 million in common stock over a two-year period.

Summary

• Artificial Intelligence Technology Solutions Inc. (AITX) signed an Equity Financing Agreement with GHS Investments, LLC (GHS) on June 11, 2025.
• The agreement allows AITX to sell up to $30,000,000 of its common stock to GHS over a 24-month term, expiring on June 11, 2027.
• AITX has the discretion to issue 'Puts' (purchase notices) to GHS, ranging from a minimum of $10,000 to a maximum of $1,500,000 per Put.
• The purchase price for shares will be 80% of the Market Price (lowest traded price during the Pricing Period), increasing to 85% if the average closing price for the three preceding trading days is $0.01 or greater.
• Following an up-list to NASDAQ or an equivalent national exchange, the purchase price will be 90% of the lowest Volume Weighted Average Price (VWAP) during the Pricing Period, subject to a $4.00 per share floor.
• GHS's beneficial ownership is capped at 4.99% of the outstanding common stock at any given time.
• A Registration Rights Agreement was also executed concurrently, covering the resale of the shares on a Form S-1 Registration Statement.
• The proceeds from the sale of shares will be used for general corporate and working capital purposes, acquisitions of assets, businesses or operations, or other purposes deemed in the best interest of the Company by the Board of Directors.

Sentiment

Score: 7

Explanation: The agreement provides a significant and flexible source of capital for the company's operations and growth initiatives, which is a positive. However, the inherent dilutive nature of the equity financing and the discounted share price are notable downsides, balancing the overall sentiment to moderately positive.

Positives

• Secures a potential capital infusion of up to $30 million, providing significant funding for general corporate purposes, working capital, and potential acquisitions.
• The agreement offers flexibility, allowing the Company to control the timing and amount of share sales based on market conditions and funding needs.
• The financing facility has a two-year term, providing a sustained source of capital.
• The Company maintains discretion over the timing and amount of 'Puts', enabling strategic capital deployment.
• The agreement includes provisions for a higher purchase price (up to 90% of VWAP with a $4.00 floor) if the Company successfully up-lists to NASDAQ or an equivalent national exchange, incentivizing growth and market presence.

Negatives

• The equity financing agreement is inherently dilutive to existing shareholders, as new shares will be issued, potentially increasing the total outstanding share count.
• The purchase price for shares is at a discount (80% to 85% of Market Price, or 90% of VWAP with a floor), which means shares are sold below market value, further contributing to dilution.
• The agreement's effectiveness is contingent on an effective Registration Statement and the Common Stock being listed or quoted on the Principal Market, introducing potential delays or conditions.
• The maximum Put amount is limited to 250% of the average daily trading volume, which could restrict the speed of capital deployment if trading volume is low.
• The Investor (GHS) is prohibited from short sales during the agreement term, which might limit liquidity or trading strategies for the investor, though this is not a direct negative for the company.

Risks

• **Dilution Risk**: The issuance of new common stock under the agreement will increase the number of outstanding shares, potentially diluting the ownership interests of existing shareholders.
• **Market Price Volatility**: The purchase price is tied to the market price or VWAP, meaning the Company will receive less capital per share if the stock price declines, exacerbating dilution.
• **Registration Statement Effectiveness**: The Company's ability to draw funds is contingent on the Registration Statement remaining effective and available for resale, and any delays or stop orders could halt funding.
• **Listing and Trading Suspension**: If the Common Stock is suspended from trading or ceases to be quoted on the Principal Market, the agreement will be suspended, cutting off access to capital.
• **Breach of Agreement**: Any breach or default by the Company under the Purchase Agreement or Registration Rights Agreement could terminate or suspend the financing facility.
• **Bankruptcy Proceedings**: The occurrence of bankruptcy proceedings by or against the Company would suspend the agreement.
• **Failure to Up-list**: If the Company does not up-list to NASDAQ or an equivalent exchange, it will not benefit from the potentially higher purchase price (90% of VWAP with a $4.00 floor).

Future Outlook

The Company intends to use the proceeds from this equity financing for general corporate and working capital purposes, as well as for potential acquisitions of assets, businesses, or operations. The agreement also includes provisions that could lead to a higher purchase price per share if the Company successfully up-lists to a national exchange like NASDAQ, indicating a strategic goal for market presence.

Management Comments

• "The Companys executive officers and directors have studied and fully understand the nature of the transactions contemplated by this Agreement and recognize that they have a potential dilutive effect on the shareholders of the Company."
• "The Board of Directors of the Company has concluded, in its good faith business judgment, and with full understanding of the implications, that such issuance is in the best interests of the Company."

Industry Context

This equity financing agreement provides Artificial Intelligence Technology Solutions Inc. with a flexible funding mechanism, which is common for growth-oriented companies, particularly in the technology and AI sectors, that require ongoing capital for R&D, operational scaling, and strategic acquisitions. Such facilities allow companies to tap into capital markets as needed, rather than through a single large offering, which can be beneficial in volatile market conditions. The mention of a potential up-list to NASDAQ suggests the company's ambition to gain broader investor exposure and potentially improve its valuation and liquidity, a common trajectory for emerging tech firms.

Comparison to Industry Standards

• The discount rates (80-85% of market price, or 90% of VWAP) for equity financing facilities like this are within typical ranges for small-cap or micro-cap companies seeking flexible capital, especially those not yet listed on major exchanges. For instance, similar facilities for companies in the AI/robotics space, such as those raising capital for product development or market expansion, often involve discounts to market price to compensate the investor for liquidity and market risk.
• The 4.99% beneficial ownership cap for GHS Investments is a standard provision in such agreements, designed to prevent the investor from triggering beneficial ownership reporting requirements (e.g., Schedule 13D) and to avoid potential 'control' issues, which is common practice across various industries for institutional investors.
• The $30 million commitment over two years provides a relatively substantial runway for a company of this size, comparable to capital raises seen in other emerging technology companies, such as robotics startups or AI software developers, that are past initial seed funding but not yet profitable or cash-flow positive.

Stakeholder Impact

• **Shareholders**: Existing shareholders will experience dilution of their ownership percentage due to the issuance of new shares. The discounted purchase price for new shares may also impact the per-share value.
• **Employees**: The capital raise provides financial stability, potentially supporting continued operations, R&D, and job security.
• **Customers**: Enhanced financial resources could lead to improved product development, service delivery, and overall business stability, benefiting customers.
• **Suppliers**: A stronger financial position may ensure timely payments and foster more stable relationships with suppliers.
• **Creditors**: The capital raise improves the company's liquidity and financial health, potentially reducing credit risk.

Next Steps

• The Company will file a Current Report on Form 8-K describing the material terms of the transaction within four trading days after the Execution Date.
• The Company will use its best efforts to file a Form S-1 Registration Statement covering the resale of the shares within 30 calendar days of the agreement's execution.
• The Company will use commercially reasonable efforts to have the Registration Statement declared effective by the SEC within 30 to 90 calendar days after filing.
• The Company will maintain the listing of its common stock on the Principal Market and work towards a potential up-list to NASDAQ or an equivalent national exchange.

Key Dates

Recommendation

Keywords

Equity Financing, Capital Raise, SEC Filing, Form 8-K, Common Stock, Dilution, GHS Investments, Artificial Intelligence Technology Solutions, AITX, Investment Agreement, Registration Rights, Public Company, Financial Reporting